Search Results

There are 127290 results for: content related to: 177 Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy

  1. High resolution digital autoradiographic and dosimetric analysis of heterogeneous radioactivity distribution in xenografted prostate tumors

    Medical Physics

    Volume 43, Issue 12, December 2016, Pages: 6632–6643, Oskar V Timmermand, Jenny Nilsson, Sven-Erik Strand and Jörgen Elgqvist

    Version of Record online : 23 NOV 2016, DOI: 10.1118/1.4967877

  2. Use of Monte Carlo simulations with a realistic rat phantom for examining the correlation between hematopoietic system response and red marrow absorbed dose in Brown Norway rats undergoing radionuclide therapy with 177Lu- and 90Y-BR96 mAbs

    Medical Physics

    Volume 39, Issue 7, July 2012, Pages: 4434–4443, Erik Larsson, Michael Ljungberg, Linda Mårtensson, Rune Nilsson, Jan Tennvall, Sven-Erik Strand and Bo-Anders Jönsson

    Version of Record online : 28 JUN 2012, DOI: 10.1118/1.4730499

  3. You have free access to this content
    High-dose radioimmunotherapy combined with extracorporeal depletion in a syngeneic rat tumor model

    Cancer

    Volume 116, Issue S4, 15 February 2010, Pages: 1043–1052, Linda Mårtensson, Rune Nilsson, Tomas Ohlsson, Hans-Olov Sjögren, Sven-Erik Strand and Jan Tennvall

    Version of Record online : 2 FEB 2010, DOI: 10.1002/cncr.24791

  4. You have free access to this content
    Toxicity and dosimetry of 177Lu-DOTA-Y3-octreotate in a rat model

    International Journal of Cancer

    Volume 94, Issue 6, 15 December 2001, Pages: 873–877, Jason S. Lewis, Mu Wang, Richard Laforest, Fan Wang, Jack L. Erion, Joseph E. Bugaj, Ananth Srinivasan and Carolyn J. Anderson

    Version of Record online : 12 SEP 2001, DOI: 10.1002/ijc.1540

  5. You have free access to this content
    Single tumor cell uptake and dosimetry of technetium-99m Fab′ anti-CD22 in low-grade B-cell lymphoma

    Cancer

    Volume 94, Issue S4, 15 February 2002, Pages: 1270–1274, Ola Lindén, Cecilia Hindorf, Jan Tennvall, Sverker Segrén, Karin Wingardh and Sven-Erik Strand

    Version of Record online : 12 FEB 2002, DOI: 10.1002/cncr.10296

  6. You have free access to this content
    Improvements in the radiotherapy of medulloblastoma, 1946–1975

    Cancer

    Volume 45, Issue 4, 15 February 1980, Pages: 670–678, Torsten G. Landberg, Martin L. Lindgren, Eva K. Cavallin-Ståhl, Gudrun O. Svahn-Tapper, Göran Sundbärg, Stanislaw Garwicz, Jan A. Lagergren, Viviann L. Gunnesson, Arne E. Brun and Sten E. Cronqvist

    Version of Record online : 28 JUN 2006, DOI: 10.1002/1097-0142(19800215)45:4<670::AID-CNCR2820450409>3.0.CO;2-K

  7. Three-dimensional radiobiological dosimetry of kidneys for treatment planning in peptide receptor radionuclide therapy

    Medical Physics

    Volume 39, Issue 10, October 2012, Pages: 6118–6128, Sébastien Baechler, Robert F. Hobbs, Ariane Boubaker, Franz Buchegger, Bin He, Eric C. Frey and George Sgouros

    Version of Record online : 21 SEP 2012, DOI: 10.1118/1.4752213

  8. Production, quality control, and determination of human absorbed dose of no carrier added 177Lu-risedronate for bone pain palliation therapy

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 60, Issue 1, January 2017, Pages: 20–29, Nafise Salek, Mohsen Mehrabi, Simindokht Shirvani Arani, Ali Bahrami Samani, Mostafa Erfani, Sara Vosoghi, Mohammad Ghannadi Maragheh and Mojtaba Shamsaei

    Version of Record online : 15 NOV 2016, DOI: 10.1002/jlcr.3466

  9. 177Lu-labeled monomeric, dimeric and multimeric RGD peptides for the therapy of tumors expressing α(ν)β(3) integrins

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 55, Issue 4, April 2012, Pages: 140–148, Myrna Luna-Gutiérrez, Guillermina Ferro-Flores, Blanca Ocampo-García, Nallely Jiménez-Mancilla, Enrique Morales-Avila, Luis De León-Rodríguez and Keila Isaac-Olivé

    Version of Record online : 6 MAR 2012, DOI: 10.1002/jlcr.2910

  10. Dosimetric results in treatments of neuroblastoma and neuroendocrine tumors with 131I-metaiodobenzylguanidine with implications for the activity to administer

    Medical Physics

    Volume 42, Issue 7, July 2015, Pages: 3969–3978, Pablo Mínguez, Glenn Flux, José Genollá, Sonía Guayambuco, Alejandro Delgado, José Cruz Fombellida and Katarina Sjögreen Gleisner

    Version of Record online : 30 NOV 2016, DOI: 10.1118/1.4921807

  11. Whole-remnant and maximum-voxel SPECT/CT dosimetry in 131I-NaI treatments of differentiated thyroid cancer

    Medical Physics

    Volume 43, Issue 10, October 2016, Pages: 5279–5287, Pablo Mínguez, Glenn Flux, José Genollá, Alejandro Delgado, Emilia Rodeño and Katarina Sjögreen Gleisner

    Version of Record online : 30 NOV 2016, DOI: 10.1118/1.4961742

  12. Model-based versus specific dosimetry in diagnostic context: Comparison of three dosimetric approaches

    Medical Physics

    Volume 42, Issue 3, March 2015, Pages: 1288–1296, S. Marcatili, D. Villoing, T. Mauxion, B. J. McParland and M. Bardiès

    Version of Record online : 30 NOV 2016, DOI: 10.1118/1.4907957

  13. SU-E-I-51: Investigation of Absorbed Dose to the Skin, Eyes and Thyroid of Patients during CT Angiography and Comparison with Conventional Angiography

    Medical Physics

    Volume 39, Issue 6, June 2012, Page: 3636, M Tavakoli H., K Jabari and J Salman

    Version of Record online : 30 NOV 2016, DOI: 10.1118/1.4734767

  14. A dose point kernel database using GATE Monte Carlo simulation toolkit for nuclear medicine applications: Comparison with other Monte Carlo codes

    Medical Physics

    Volume 39, Issue 8, August 2012, Pages: 5238–5247, Panagiotis Papadimitroulas, George Loudos, George C. Nikiforidis and George C. Kagadis

    Version of Record online : 1 AUG 2012, DOI: 10.1118/1.4737096

  15. You have free access to this content
    Absorbed dose profiles for radionuclides of frequent use in radiation synovectomy

    Arthritis & Rheumatism

    Volume 34, Issue 12, December 1991, Pages: 1521–1530, L. Johnson Scott and Jacquelyn C. Yanch

    Version of Record online : 26 AUG 2010, DOI: 10.1002/art.1780341208

  16. SU-FF-T-07: Treatment Planning Considerations and the Effect of Tissue Heterogeneities On the Absorbed Dose Distribution From the Xoft Axxent 50 KVp Electronic Brachytherapy Source

    Medical Physics

    Volume 36, Issue 6, June 2009, Page: 2520, J DeMarco, B Fahimian, K Iwamoto and R Holt

    Version of Record online : 9 JUL 2009, DOI: 10.1118/1.3181478

  17. Absorbed dose to water reference dosimetry using solid phantoms in the context of absorbed-dose protocols

    Medical Physics

    Volume 32, Issue 9, September 2005, Pages: 2945–2953, Jan Seuntjens, Marina Olivares, Michael Evans and Ervin Podgorsak

    Version of Record online : 30 NOV 2016, DOI: 10.1118/1.2012807

  18. TU-D-BRB-01: Comparison of the Response of EBT Emulsion to 90Sr/Y Beta Particles and 60Co Gamma Rays

    Medical Physics

    Volume 36, Issue 6, June 2009, Page: 2731, C Soares, R Minniti, G Massillon-JL, E Meek and J Walia

    Version of Record online : 9 JUL 2009, DOI: 10.1118/1.3182367

  19. Graves' disease radioiodine-therapy: Choosing target absorbed doses for therapy planning

    Medical Physics

    Volume 41, Issue 1, January 2014, J. Willegaignon, M. T. Sapienza, G. B. Coura-Filho, T. Watanabe, A. C. Traino and C. A. Buchpiguel

    Version of Record online : 30 NOV 2016, DOI: 10.1118/1.4846056

  20. Radiation dose distribution within the bone marrow of patients receiving holmium-166-labeled-phosphonate for marrow ablation

    Medical Physics

    Volume 22, Issue 6, June 1995, Pages: 743–753, J. E. Bayouth, D. J. Macey, A. L. Boyer and R. E. Champlin

    Version of Record online : 30 NOV 2016, DOI: 10.1118/1.597491